Search - tctmd.com

Displaying 481 - 500 of 957

Sort: Relevancy | Date

Presentation

Long-term Safety and Efficacy in Continued Access Left Atrial Appendage Closure Registries

December 02, 2019

News Daily News

Long-term Watchman Data Reassure: CAP and CAP2 Registries

Michael O'Riordan

December 02, 2019

TAVR in Bicuspid Aortic Valves: Insights From BIVOLUT-X

Michael O'Riordan

November 22, 2019

News Conference News PCR London Valves 2019

Solid 2-Year Outcomes for Portico, With Paravalvular Leak Rare

Michael O'Riordan

November 20, 2019

News Conference News PCR London Valves 2019

Signal of Impaired Sapien XT Durability in Midterm Follow-up

Michael O'Riordan

November 20, 2019

News Conference News PCR London Valves 2019

Two Small Series Support Role for Cerebral Protection in TAVR

Michael O'Riordan

November 18, 2019

News Conference News AHA 2019

Full GALILEO Results Confirm Harm With Rivaroxaban After TAVR

Todd Neale

November 17, 2019

News Conference News AHA 2019

Early Surgery Beats a Conservative Approach in Asymptomatic AS: RECOVERY

Yael L. Maxwell

November 16, 2019

Presentation Controversies and Advances 2019

Left Atrial Appendage Occlusion: A Valid Option to Anticoagulation for Stroke Prevention

Presenter: Tarun Chakravarty

November 15, 2019

News Conference News AHA 2019

AHA 2019: Beyond ISCHEMIA Are Plenty of Coronary, Structural, and HF Trials

Shelley Wood

November 11, 2019

News Daily News

Sapien 3 Valve Approved in Europe for Low-Risk Patients

Michael O'Riordan

November 06, 2019

News Industry News

Edwards SAPIEN 3 TAVI Receives Expanded Approval In Europe

November 06, 2019

News Daily News

Cardioversion Without Anticoagulation Appears Safe in Patients With Watchman

Todd Neale

November 01, 2019

News Daily News

Expert Consensus Aims to Promote Cardiac CT Use in Preprocedural LAA Occlusion

Yael L. Maxwell

November 01, 2019

News Daily News

Better Survival 3 Years After TAVR for Patients With Mixed Aortic Valve Disease

L.A. McKeown

November 01, 2019

News Daily News

Better Closure, More A-fib With Cardioform for PFO Closure: Retrospective Series

Yael L. Maxwell

October 30, 2019

Presentation TCT Abstracts Posters 2019

Incidence, predictors and outcomes of periprocedural stroke in patients undergoing TAVR: Report from National Inpatient sample

Presenter: Moinuddin Syed

October 28, 2019

News Daily News

New-Onset A-fib Tied to Particularly Poor Outcomes After TAVR

Todd Neale

October 18, 2019

News Conference News TCT 2019

Early Mortality Rates After TAVR Halved in a Decade, With Some Gender Differences

L.A. McKeown

October 09, 2019

News Daily News

PARTNER 2A at EACTS 2019: ‘The Message Is Exactly the Same’

Shelley Wood

October 08, 2019

Advertisement

Long-term Safety and Efficacy in Continued Access Left Atrial Appendage Closure Registries

Long-term Watchman Data Reassure: CAP and CAP2 Registries

TAVR in Bicuspid Aortic Valves: Insights From BIVOLUT-X

Solid 2-Year Outcomes for Portico, With Paravalvular Leak Rare

Signal of Impaired Sapien XT Durability in Midterm Follow-up

Two Small Series Support Role for Cerebral Protection in TAVR

Full GALILEO Results Confirm Harm With Rivaroxaban After TAVR

Early Surgery Beats a Conservative Approach in Asymptomatic AS: RECOVERY

Left Atrial Appendage Occlusion: A Valid Option to Anticoagulation for Stroke Prevention

AHA 2019: Beyond ISCHEMIA Are Plenty of Coronary, Structural, and HF Trials

Sapien 3 Valve Approved in Europe for Low-Risk Patients

Edwards SAPIEN 3 TAVI Receives Expanded Approval In Europe

Cardioversion Without Anticoagulation Appears Safe in Patients With Watchman

Expert Consensus Aims to Promote Cardiac CT Use in Preprocedural LAA Occlusion

Better Survival 3 Years After TAVR for Patients With Mixed Aortic Valve Disease

Better Closure, More A-fib With Cardioform for PFO Closure: Retrospective Series

Incidence, predictors and outcomes of periprocedural stroke in patients undergoing TAVR: Report from National Inpatient sample

New-Onset A-fib Tied to Particularly Poor Outcomes After TAVR

Early Mortality Rates After TAVR Halved in a Decade, With Some Gender Differences

PARTNER 2A at EACTS 2019: ‘The Message Is Exactly the Same’

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content